Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | RATHOD TRADING COMPANY | Awarded | 1 | ₹50,960 |
| 2 | Schedule 2 | RATHOD TRADING COMPANY | Awarded | 1 | ₹76,450 |
Tender Value
₹1.3 L
EMD Value
Exempted
Closing Date
27 Jan 2024, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Conc Anti Activating transcription factor3 (ATF3) IHC Antibody (Q3)
Conc Anti Neuromedin B Polyclonal antibody (NmB) IHC (Q3)
5612056
GEM/2023/B/4223223
Two Packet Bid
Conc Anti Activating transcription factor3 (ATF3) IHC Antibody,Conc Anti Neuromedin B Polyclonal an
45 days
Maharashtra; Pune
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Conc Anti Activating transcription factor3 (ATF3) IHC Antibody (Q3) | PUNE | 1 | 45 days | |
| Conc Anti Neuromedin B Polyclonal antibody (NmB) IHC (Q3) | PUNE | 1 | 45 days |
Exempted
27 Jan 2024
6 Jan 2024
27 Jan 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5612056.pdf
GEM_BID
pathologyspecification_modified_2023-11-17-16-57-39_3a98368fe90821d0c809631902b6e88d.pdf
SPECIFICATION
pathologyspecification_modified_2023-11-17-16-53-46_80b66f5437fefa06b81d64094390e60d.pdf
SPECIFICATION
1701427226.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .